Efficacy from the ongoing phase I trial Study 1100 with NBTXR3 activated by radiotherapy in combination with nivolumab or pembrolizumab in patients with locoregionally recurrent or metastatic HNSCC

For inquiries about our technology, collaborations, clinical trials, or other topics, we encourage you to get in touch with our team.